Select a medication above to begin.
Tafinlar
dabrafenib
Adult Dosing .
Dosage forms: CAP: 50 mg, 75 mg; DISPERSE TAB: 10 mg
Special Note
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments
BRAF V600E- or V600K-positive melanoma
- [adjuvant tx]
- Dose: 150 mg PO bid for up to 1y; Info: use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
- [unresectable or metastatic dz]
- Dose: 150 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
BRAF V600E-positive melanoma
- [unresectable or metastatic dz, monotherapy]
- Dose: 150 mg PO bid; Info: give at least 1h before or 2h after meals; do not open cap
BRAF V600E-positive non-small cell lung CA, metastatic
- [150 mg PO bid]
- Info: use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
BRAF V600E-positive anaplastic thyroid CA, locally advanced or metastatic
- [150 mg PO bid]
- Info: use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
BRAF V600E-positive solid tumors, unresectable or metastatic
- [150 mg PO bid]
- Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
BRAF V600E-positive glioma, low-grade
- [150 mg PO bid]
- Info: use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
renal dosing
- [see below]
- eGFR >15: no adjustment; eGFR <15: not defined
- HD/PD: not defined
hepatic dosing
- [see below]
- bilirubin 1.1-1.5x ULN or AST >ULN: no adjustment; bilirubin >1.5x ULN: not defined
Peds Dosing .
- Dosage forms: CAP: 50 mg, 75 mg; DISPERSE TAB: 10 mg
Special Note
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments
BRAF V600E-positive solid tumors, unresectable or metastatic
- [cap form, 1 yo and older, 26-37 kg]
- Dose: 75 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
- [cap form, 1 yo and older, 38-50 kg]
- Dose: 100 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
- [cap form, 1 yo and older, >51 kg]
- Dose: 150 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
- [disperse tab form, 1 yo and older, 8-9 kg]
- Dose: 20 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 10-13 kg]
- Dose: 30 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 14-17 kg]
- Dose: 40 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 18-21 kg]
- Dose: 50 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 22-25 kg]
- Dose: 60 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 26-29 kg]
- Dose: 70 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 30-33 kg]
- Dose: 80 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 34-37 kg]
- Dose: 90 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 38-41 kg]
- Dose: 100 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 42-45 kg]
- Dose: 110 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 46-50 kg]
- Dose: 130 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, >51 kg]
- Dose: 150 mg PO bid; Info: for pts who have progressed after prior tx; not for pts w/ colorectal CA; use w/ trametinib; give at least 1h before or 2h after meals
BRAF V600E-positive glioma, low-grade
- [cap form, 1 yo and older, 26-37 kg]
- Dose: 75 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
- [cap form, 1 yo and older, 38-50 kg]
- Dose: 100 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
- [cap form, 1 yo and older, >51 kg]
- Dose: 150 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals; do not open cap
- [disperse tab form, 1 yo and older, 8-9 kg]
- Dose: 20 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 10-13 kg]
- Dose: 30 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 14-17 kg]
- Dose: 40 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 18-21 kg]
- Dose: 50 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 22-25 kg]
- Dose: 60 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 26-29 kg]
- Dose: 70 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 30-33 kg]
- Dose: 80 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 34-37 kg]
- Dose: 90 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 38-41 kg]
- Dose: 100 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 42-45 kg]
- Dose: 110 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, 46-50 kg]
- Dose: 130 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
- [disperse tab form, 1 yo and older, >51 kg]
- Dose: 150 mg PO bid; Info: use w/ trametinib; give at least 1h before or 2h after meals
renal dosing
- [see below]
- eGFR >15: no adjustment; eGFR <15: not defined
- HD/PD: not defined
hepatic dosing
- [see below]
- bilirubin 1.1-1.5x ULN or AST >ULN: no adjustment; bilirubin >1.5x ULN: not defined